Our Metered Dose Inhaler (MDI) delivers a repeatable and accurate dose of cannabinoids with every actuation. The technology and delivery method has been widely used for decades in the treatment of asthma and COPD. It produces no smoke, has no adverse smell and allows a discreet and convenient delivery of medication in any setting. Its rapid onset also provides relief within a few minutes. Our direct-to-lung delivery method results in increased bioavailability and reduces waste cannabinoids.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Blackpoint Biotech PLC
Blackpoint Biotech provides patients with the ability to receive measured, repeatable and fast acting doses of cannabinoids to effectively target their conditions.
Blackpoint Biotech is committed to revolutionising the medical cannabis industry by developing innovative and advanced products that deliver rapid onset of action, accurate dosing and high bioavailability. By addressing one of the largest gaps in the sector we aim to provide safe and controlled medical cannabis solutions that truly benefit patients.
We believe cannabinoids can be an effective treatment for certain medical conditions. To fully benefit - as with any medication - doctors and patients require the ability to deliver dosages that are reliable, controllable and consistent. Blackpoint Biotech’s medical cannabinoid inhalers and sublingual sprays provide this.
blackpointbiotech.com